Cargando...
Combining radiotherapy with sunitinib: lessons (to be) learned
To improve the efficacy of radiotherapy (RTx), there is a growing interest in combining RTx with drugs that inhibit angiogenesis, i.e., the process of neo-vessel formation out of preexisting capillaries. A frequently used drug to inhibit angiogenesis is sunitinib (Sutent, SU11248), a receptor tyrosi...
Gardado en:
| Publicado en: | Angiogenesis |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Springer Netherlands
2015
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4596900/ https://ncbi.nlm.nih.gov/pubmed/26202788 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10456-015-9476-3 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|